Paudel, P.; Seong, S.H.; Zhou, Y.; Park, C.H.; Yokozawa, T.; Jung, H.A.; Choi, J.S.
Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease. Molecules 2018, 23, 2919.
https://doi.org/10.3390/molecules23112919
AMA Style
Paudel P, Seong SH, Zhou Y, Park CH, Yokozawa T, Jung HA, Choi JS.
Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease. Molecules. 2018; 23(11):2919.
https://doi.org/10.3390/molecules23112919
Chicago/Turabian Style
Paudel, Pradeep, Su Hui Seong, Yajuan Zhou, Chan Hum Park, Takako Yokozawa, Hyun Ah Jung, and Jae Sue Choi.
2018. "Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease" Molecules 23, no. 11: 2919.
https://doi.org/10.3390/molecules23112919
APA Style
Paudel, P., Seong, S. H., Zhou, Y., Park, C. H., Yokozawa, T., Jung, H. A., & Choi, J. S.
(2018). Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease. Molecules, 23(11), 2919.
https://doi.org/10.3390/molecules23112919